Publications
5808 Results
- Journal / Conference
- Biomarkers Jan 29:1-10
- Year
- 2023
- Research Committee(s)
- Breast
- PMID
- PMID36647745
- PMC
- PMC10681159
- Study Number(s)
- S0226
Thymidine Kinase Activity Levels in Serum Can Identify HR+ Metastatic Breast Cancer Patients with a Low Risk of Early Progression (SWOG S0226)
- Journal / Conference
- New England Journal of Medicine Mar 2;388(9):813-823
- Year
- 2023
- Research Committee(s)
- Melanoma
- PMID
- PMID36856617
- PMC
- PMC10410527
- Study Number(s)
- S1801
Neoadjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma
- Journal / Conference
- Journal of Clinical Oncology Jun 1;41(16):2949-2962
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID36795987
- PMC
- PMC10414715
- Study Number(s)
- S0106, S0112, SWOG-9031, SWOG-9333
Long Non-coding RNA Expression Independently Predicts Outcome in Pediatric Acute Myeloid Leukemia
- Journal / Conference
- Journal of Happiness Studies 24:231-247
- Year
- 2023
Healthcare Professionals’ Lay Definitions of Hope
- Journal / Conference
- Cancer Medicine Apr;12(7):8211-8217
- Year
- 2023
- Research Committee(s)
- Lymphoma
- PMID
- PMID36799072
- PMC
- PMC10134372
Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis
- Journal / Conference
- New England Journal of Medicine Feb 9;388(6):489-498
- Year
- 2023
- Research Committee(s)
- Lung
- PMID
- PMID36780674
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer
- Journal / Conference
- Journal of the National Cancer Institute Jan 10;115(1):21-28
- Year
- 2023
- Research Committee(s)
- Symptom Management and Survivorship
- PMID
- PMID36266760
- PMC
- PMC9830479
Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials
- Journal / Conference
- Scientific Reports Apr 12;13(1):5968. doi: 10.1038/s41598-023-31840-0
- Year
- 2023
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID37045850
- PMC
- PMC10097673
- Study Number(s)
- S0000
Application of Mendelian randomization to explore the causal role of the human gut microbiome in colorectal cancer
- Journal / Conference
- European Urology Oncology Apr 20;S2588-9311(23)00074-3
- Year
- 2023
- Research Committee(s)
- Genitourinary
- PMID
- PMID37087309
- PMC
- PMC10587361
- Study Number(s)
- S1314
Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314
- Journal / Conference
- Journal of the National Cancer Institute Jun 8;115(6):703-711
- Year
- 2023
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID36946291
- PMC
- PMC10248838
- Study Number(s)
- S1204